Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
Ventricular arrhythmia in a male MS patient on fingolimod.
Associations of Systemic Diseases with Intermediate Uveitis.
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis.
Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
[Multiple sclerosis and pregnancy].
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Epigenetic mechanisms in neurological and neurodegenerative diseases.
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
The role of melatonin in the pathogenesis of multiple sclerosis: a case-control study.
Evidence of aquaporin involvement in human central pontine myelinolysis.
Clinical Outcome of 50 Progressive Multiple Sclerosis Patients Treated with Cellular Therapy in Iraq.
Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.
Time to target brain atrophy and neurodegeneration in multiple sclerosis.
Early and Extensive Spinal White Matter Involvement in Neuromyelitis Optica.
Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.
Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens.
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study.
Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
Pages
« first
‹ previous
…
614
615
616
617
618
619
620
621
622
…
next ›
last »